Encouraging efficacy and safety results of the phase II ROAR basket study support tumor-agnostic therapy in patients with rare cancers and suggest that genetic testing and tumor profiling should be in...
Read moreHan demostrado que el tratamiento con un fármaco de diseño que modifica el procesado del ARN puede ralentizar la neurodegeneración típica de la esclerosis lateral amiotrófica (ELA). Sus resultado...
Read moreMineralys Therapeutics today announced the first patient dosed in the ADVANCE-HTN pivotal trial to evaluate the safety and efficacy of lorundrostat for the treatment of uncontrolled hypertension (uHTN...
Read moreA phase III clinical trial comparing the efficacy the combination of Trifluridine/tipiracil plus the antibody bevacizumab versus Trifluridine/tipiracil in patients with refractory metastatic colonrect...
Read moreibs.GRANADA researchers have developed calcium phosphate nanoparticles to transport antitumor drugs used in pancreatic cancer that improve their effect on this type of tumor
Read moreAtrys Health, compañía global que presta servicios de prevención, diagnóstico y tratamiento médico de precisión y pionera en telemedicina y radioterapia de última generación, ha sido la primer...
Read moreEl tratamiento con blinatumomab mejora notablemente la supervivencia en pacientes infantiles que acaban de ser diagnosticados con leucemia linfoblástica aguda asociada a reorganizaciones en el gen KM...
Read moreResults of the phase 3 COSMIC-313 trial show that the addition of targeted kinase inhibitor cabozantinib to dual checkpoint inhibition with nivolumab and ipilimumab in patients with advanced or metast...
Read moreThe new study, published in Nature Cardiovascular Research, will help to select the most effective and safe way to modulate angiogenesis in ischemic tissues or in cancer
Read moreResults from the Phase III TALAPRO-2 trial demonstrate that the combination of talazoparib plus enzalutamide vs. standard treatment of enzalutamide plus placebo significantly improves progression-free...
Read moreEl Hospital 12 de Octubre participa en un ensayo clínico internacional que demuestra que un inhibidor denominado vorasidenib, que se administra vía oral, detiene varios años la progresión de un ti...
Read moreVHIO led and participated in a dozen studies on lung cancer that were presented at the American Society of Clinical Oncology (ASCO) meeting held June 2-6 in Chicago.
Read more